课题基金 / 基金详情

基于蜕膜巨噬细胞外泌体miRNA调控TLR-4/NF-κB信号通路探讨补肾活血法干预URSA的分子机制

批准号:
82074167
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
徐广立
依托单位:
学科分类:
中西医结合临床基础
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
徐广立

项目摘要

结项摘要

相似基金

相关文献

中文摘要
母胎界面免疫紊乱诱发微血栓形成与不明原因复发性流产(URSA)密切相关。课题组前期采用补肾活血法获得可靠临床疗效,并发现药物可能是通过TLR-4/NF-κB信号通路减少血管内皮细胞(EC)损伤而发挥作用,但机制不清;近期研究发现蜕膜巨噬细胞(DM)外泌体参与局部免疫调节,其携带的miRNA可调控EC功能。由此推测:补肾活血法可能干预了DM外泌体传递的miRNA,通过TLR-4/NF-κB通路调控EC而减少血栓形成。采用CBA/J-DBA/2孕鼠流产模型,用经验方丹寿汤干预后高通量测序DM外泌体miRNA表达谱,差异分析及靶基因预测和通路富集分析;用Transwell建立EC与DM共培养体系,设外泌体拮抗剂与药物血清干预对照,观察DM分泌和EC摄取外泌体能力、TLR-4/NF-κB信号通路关键分子mRNA及前期筛查的高差异表达miRNA水平,探索中药干预母胎界面DM外泌体miRNA调控机制。
英文摘要
Microthrombus formation induced by maternal-fetal interface immune disorder is closely related to unexplained recurrent spontaneous abortion (URSA) . In the early stage, the research group adopted kidney-tonifying and blood-activating method to obtain reliable clinical efficacy. It was also found that the drug may act through the endothelial TLR-4 /NF-κB signal pathway. But the mechanism is unclear. Recent studies have found that decidual macrophages (DM) exosomes participate in local immune regulation, the miRNA it carries regulates the function of endothelial cells. We speculated that the method of kidney tonifying and blood activating may interfere with DM exosomes and the miRNA transmitted. Endothelial cells are regulated by the TLR-4 /NF- B pathway to reduce thrombosi. CBA/J-DBA /2 mice abortion model was adopted. The differential expression profile of miRNA in DM exosomes was detected by high-throughput sequencing after the intervention of empirical Danshou decoction. Bioinformatics method was used for target gene prediction and pathway enrichment analysis. The co-culture system of EC and DM was established by Transwell methods, and the exosome antagonist group and drug serum intervention control group were set up. The ability of endothelial cells absorbing exosomes, the mRNA levels of key molecules of TLR-4 /NF- κB signaling pathway and the high differential expression of miRNA in the previous screening were detected. The purpose of these is to analyze the miRNA regulation mechanism of TCM intervention on maternal-fetal exosomes.
复发性流产(Recurrent spontaneous abortion,RSA)是一种常见的临床妊娠并发症,其中有近40 %原因尚不清楚,被称为不明原因的复发性流产(Unexplained recurrent spontaneous abortion,URSA)。丹寿汤可用于治疗复发性流产,但其具体分子作用机制尚未被全面阐明。因此,本课题构建流产小鼠模型(以下简称RSA)并给予丹寿汤进行治疗;鉴于蜕膜巨噬细胞外泌体miRNA与RSA密切相关,我们提取蜕膜巨噬细胞外泌体进行高通量测序分析miRNA表达谱;目前研究表明,胎盘血管发育不良和内皮功能障碍可能引起胎盘组织的病理改变导致RSA的发生,因此我们在细胞水平上阐明丹寿汤是否通过差异表达miRNA——miR-744-3p调控其下游预测基因TLR4进而降低内皮细胞损伤干预RSA的分子机制。.高通量分析结果显示,与RSA模型组相比,丹寿汤干预组小鼠蜕膜巨噬细胞外泌体中有5个显著上调的miRNA和9个显著下调的miRNA,其中包含miR-744-3p,说明丹寿汤可能通过调控这14个miRNA的表达水平缓解RSA疾病进展。体外研究表明miR-744-3p促进内皮细胞增殖、迁移、成管,且双荧光素酶报告实验结果显示miR-744-3p靶向抑制TLR4表达,说明丹寿汤可能通过调节miR-744-3p/TLR4干预RSA。.综上所述,我们得出结论:①丹寿汤调控RSA蜕膜巨噬细胞外泌体miRNA表达,影响相关生物学功能及信号通路转导;②丹寿汤通过调节miR-744-3p/TLR4降低内皮细胞损伤。该项目结果不仅为丹寿汤在临床上的合理应用提供了坚实的理论依据,还为临床RSA新型药物的研发提供新的参考分子靶点,对治疗RSA具有极其重要的科学意义。
国内基金
海外基金